Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis

被引:8
作者
Ajeganova, S. [1 ,2 ]
Svensson, B. [3 ]
Huizinga, T. W. J. [2 ]
van der Helm-van Mil, A. H. M. [2 ]
van Steenbergen, H. W. [2 ]
机构
[1] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med,Rheumatol Unit, S-14186 Huddinge, Sweden
[2] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[3] Lund Univ, Dept Clin Sci, Rheumatol Sect, Lund, Sweden
关键词
D O I
10.1136/annrheumdis-2015-208954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E14 / U5
页数:2
相关论文
共 7 条
[1]   Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms [J].
Ajeganova, S. ;
van Steenbergen, H. W. ;
van Nies, J. A. B. ;
Burgers, L. E. ;
Huizinga, T. W. J. ;
van der Helm-van Mil, A. H. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) :867-873
[2]   Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? [J].
de Rooy, Diederik P. C. ;
van der Linden, Michael P. M. ;
Knevel, Rachel ;
Huizinga, Tom W. J. ;
van der Helm-van Mil, Annette H. M. .
RHEUMATOLOGY, 2011, 50 (01) :93-100
[3]  
Humphreys JH, 2015, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2015-207326, DOI 10.1136/ANNRHEUMDIS-2015-207326]
[4]   The Minimally Important Difference for the Health Assessment Questionnaire in Rheumatoid Arthritis Clinical Practice Is Smaller Than in Randomized Controlled Trials [J].
Pope, Janet E. ;
Khanna, Dinesh ;
Norrie, Deborah ;
Ouimet, Janine M. .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) :254-259
[5]   Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage [J].
Shi, Jing ;
Knevel, Rachel ;
Suwannalai, Parawee ;
van der Linden, Michael P. ;
Janssen, George M. C. ;
van Veelen, Peter A. ;
Levarht, Nivine E. W. ;
van der Helm-van Mil, Annette H. M. ;
Cerami, Anthony ;
Huizinga, Tom W. J. ;
Toes, Rene E. M. ;
Trouw, Leendert A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (42) :17372-17377
[6]   Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate -: A two-year randomized trial [J].
Svensson, B ;
Boonen, A ;
Albertsson, K ;
van der Heijde, D ;
Keller, C ;
Hafström, I .
ARTHRITIS AND RHEUMATISM, 2005, 52 (11) :3360-3370
[7]   Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials [J].
Ward, Michael M. ;
Guthrie, Lori C. ;
Alba, Maria I. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (09) :1691-1696